Long - acting
risperidone increases medication costs and does not improve outcomes in unstable schizophrenia
Not exact matches
To prove that it was the «shifted» microbiome that was responsible for this metabolic change and the weight gain, the researchers transferred the microbiome from
risperidone - fed mice into control mice and saw the same effect: decreased resting metabolic rate and
increased weight gain.
Risperidone is used to treat various psychiatric disorders in adults and children, including autism, bipolar disorder, and schizophrenia, and prescribing rates for children have
increased nearly eight-fold over the last two decades.
Researchers found that the use of APMs in pregnancy does not meaningfully
increase the risk of congenital malformations or cardiac malformations, with the possible exception of
risperidone.
After controlling for other possible contributing mental and physical conditions and their associated behaviors, researchers found no significant
increased risk for either congenital malformations or cardiac malformations among women who took either typical or atypical APMs in the first 90 days of pregnancy, with the possible exception of
risperidone which continued to show a slightly
increased risk.
«Further research is needed to assess whether the
increased risk for
risperidone reflects a true casual association or a chance finding,» Huybrechts said.
Researchers linked the appetite -
increasing effects of three such drugs — the so - called atypical antipsychotics clozapine (Clozaril), olanzapine (Zyprexa), and
risperidone (Risperdal)-- to their capacity to neutralize the protein histamine, just as the antihistamine drugs that are used to treat allergies do.
The generic
risperidone products will have the same safety warnings as Risperdal, including a boxed warning, cautioning that older patients with dementia - related psychosis treated with atypical anti-psychotic drugs are at
increased risk of death, as compared with those taking placebo.
The possible exception was
risperidone, which was associated with a slightly
increased risk.
Risperidone maintenance treatment
increases time to symptom recurrence in young people with disruptive behaviour disorders